Roche Launches COVID-19 At-Home Test for Easy Self Testing

Key Highlights
  • COVID-19 At-home test enables individuals to test themselves for COVID-19 anytime, anywhere using a simple nasal swab.

  • The Nasal sampling allows for collection of the sample from the front area of the nose instead of the nasopharynx resulting in a less invasive testing experience for patients

  • Delivers results in 15 minutes.

Mumbai, 27 January 2022 – Roche Diagnostics India is excited to announce its next diagnostic solution – the COVID-19 At-Home Test. The over-the-counter test is intended to be used for detection of SARS CoV-2 infection in individuals with symptoms suggestive of COVID-19 and is approved by ICMR. The company has already brought a wide range of  COVID-19 testing solutions to the country including the gold standard RT-PCR test, a lab-based antigen test, and Rapid Antigen tests for professional use.

COVID-19 At-Home Test can successfully detect SARS-CoV-2 virus including the Omicron variant.

By following simple instructions, individuals can perform the self-test at home without special training or the supervision of a healthcare worker and expect results in 15 minutes.

The Test collects the sample from the front area of the nose instead of the nasopharynx, resulting in a simplified and more comfortable sampling procedure. The test will be available in e-pharmacies and local pharmacies and requires no prescription.

Commenting on the launch, Narendra Varde, Managing Director - Roche Diagnostics India & Neighbouring Markets said, “Roche has been at the forefront of reliable and benchmark diagnostic solutions for 125 years. COVID-19 At-Home Test is the newest addition to Roche's comprehensive COVID-19 test solutions and allows convenient anytime, anywhere access to testing. As the third wave sets in, accessibility to such simple, convenient, fast  and instrument-free self-test can contribute significantly to help us better manage our lives and health during the ongoing pandemic.”

The self-test kit includes a test cassette, a sterile swab, a tube with liquid and nozzle cap, along with a step-by-step self-test guide and QR code to access the instruction video. Users will have to download the ‘My Covid-M’ app using the QR code which will help them read and interpret the test results and also update the results to the ICMR database (as mandated by ICMR).

The tube with liquid neutralizes the SARS-CoV-2 virus. The test kit will also include a biomedical waste disposal bag for the kit following testing. In case of any difficulty in understanding the instructions or inferring the result, users can access a toll-free number to resolve their queries.

As lockdowns ease and people resume economic and social activities, reliable and convenient self-tests will play a vital role in helping people take informed decisions after duly assessing infection status and risk.

Since February 2021, Roche Diagnostics has partnered with the Swiss government in its COVID-19 screening program in Switzerland, where all citizens can receive 5 rapid antigen tests per month for free from pharmacies.

About Roche Diagnostics India

Roche is the world’s largest biotech company. Roche Diagnostics India Pvt. Ltd. established in the year 2002 has offices located in Chennai, Delhi, Kolkata and Mumbai with over 400 employees. Our broad range of innovative diagnostic tests and systems play a pivotal role in the groundbreaking area of integrated healthcare solutions and cover early detection, targeted screening, evaluation and monitoring of disease. Roche Diagnostics India works with the objective of “Doing now what patients need next”, thus preparing for the nation’s future healthcare needs.

All trademarks used or mentioned in this release are protected by law.


For Further Information, Please Contact

Roche Diagnostics India Media Relations

e-mail: [email protected]


Manjira Sharma

Phone: +91 9619123061

Email[email protected]